Cancer Research Communications Issues Research Articles in September 2023 Edition
October 05, 2023
October 05, 2023
PHILADELPHIA, Pennsylvania, Oct. 5 -- Cancer Research Communications, a peer-reviewed journal from the American Association for Cancer Research that says it stimulates innovation in cancer science and medicine, published research articles on the following topics in its September 2023 edition (Vol. 3, Issue 9):
* Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor
* PARP Inhibitors Effectively Red . . .
* Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor
* PARP Inhibitors Effectively Red . . .